Código QR (código de barras bidimensional)

Efficacy of Osimertinib in Patients With Postoperative Recurrent Non–Small‐Cell Lung Cancer Harboring Sensitizing EGFR Mutations

ABSTRACT Background The efficacy of osimertinib in patients with postoperative recurrent non–small‐cell lung cancer (NSCLC) compared to those with Stage IV NSCLC harboring epidermal growth factor receptor (EGFR) mutations remains unclear. Methods This study evaluated the efficacy of osimertinib in p...

ver descrição completa

Na minha lista:
Principais autores: Yuko Iida, Hirotsugu Kenmotsu, Keita Mori, Meiko Morita, Motoki Sekikawa, Michitoshi Yabe, Kosei Doshita, Keita Miura, Hiroaki Kodama, Noboru Morikawa, Nobuaki Mamesaya, Haruki Kobayashi, Ryo Ko, Kazushige Wakuda, Akira Ono, Tateaki Naito, Haruyasu Murakami, Yasuhisa Ohde, Yasuhiro Gon, Toshiaki Takahashi
Formato: Artigo
Idioma:Inglês
Publicado em: Wiley 2026-04-01
coleção:Thoracic Cancer
Assuntos:
EGFR
mutation
non–small‐cell lung cancer
osimertinib
postoperative recurrent
Acesso em linha:https://doi.org/10.1111/1759-7714.70285
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados